HOME Top Market Reports Respiratory Care Devices Market Therapeutic (Humidifiers, Nebulizers, PAP devices, Ventilators, Inhalers), Monitoring (Pulse Oximeter, Capnographs, disposables), Diagnostic Spirometer, Polysomnograph) & Preterm care (Nasal CPAP, Oxygen hoods, ECMO, NO delivery units, ventilators) - Global Trends & Forecasts up till 2015

Respiratory Care Devices Market Therapeutic (Humidifiers, Nebulizers, PAP devices, Ventilators, Inhalers), Monitoring (Pulse Oximeter, Capnographs, disposables), Diagnostic Spirometer, Polysomnograph) & Preterm care (Nasal CPAP, Oxygen hoods, ECMO, NO delivery units, ventilators) - Global Trends & Forecasts up till 2015

By: marketsandmarkets.com
Publishing Date: April 2011
Report Code: MD 1583

Discount on Reports  

  Speak to Analyst Enquiry Before Buying
Analyst Briefing  
purchase report
download pdf  request for customisation


The global respiratory care devices market has grown significantly over the past few years and is expected to grow at a steady pace in the coming five years. Rapidly aging population, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), technical advances in the respiratory care devices market, and tight budgets of healthcare institutions are the major factors influencing the market.

Positive airway pressure devices command the largest share in the respiratory care therapeutic devices segment. Technical advances such as portability, and increased battery life are primarily influencing the growth of this market.

The emergence of home healthcare has opened new avenues for the respiratory care devices market. Convenience and comfort in a home care environment coupled with cost advantages are the major factors driving the home healthcare market for respiratory care devices. The U.S. accounts for the largest share of the global respiratory care devices market. Demographic changes and rising incidence of COPD are among the major factors influencing the market. COPD is the fourth leading cause of death in the U.S.; about 12 million Americans suffer from COPD.

The global respiratory care market was expected to be worth $8.8 billion in 2010 and is estimated to reach $13.5 billion by 2015, growing at a CAGR of 8.8% from 2010-2015. The therapeutics devices market dominates the global respiratory care market, followed by monitoring devices and disposables. Within the therapeutics device market, positive airway pressure devices accounts for the largest share and is expected to be $5.2 billion by the year 2015. The pulse oximeters market dominates the respiratory monitoring devices segment and is expected to reach a market size of $1.7 billion by the year 2015. Within the respiratory diagnostic devices segment, spirometers dominate the market with an estimated share of $489 million by 2015.

Scope of the report

This research report includes following segments:

  • Respiratory care diagnostic devices (spirometers, peak flow meters, polysomnography devices, and other diagnostic devices)
  • Respiratory care therapeutic devices (humidifiers, nebulizers, oxygen concentrators, positive airway pressure devices, reusable resuscitators, ventilators, and respiratory inhalers)
  • Respiratory care monitoring devices and respiratory disposables (respiratory care monitoring devices pulse oximeter, capnographs and gas analyzers; respiratory disposables - disposable oxygen masks, resuscitators, tracheostomy tubes and oxygen cannulae)
  • Preterm respiratory care devices (infant ventilator, oxygen hood, nasal CPAP, ECMO (extracorporeal membrane oxygenation), nitric oxide delivery unit, resuscitators)

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report also provides 14 company profiles covering all the sub-segments.

What makes our reports unique?

We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.

  • We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  • We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
  • Comprehensive market analysis for the following sectors:

Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

  • Which are the high-growth segments/cash cows and how is the market segmented in terms of applications and materials?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

TABLE OF CONTENTS 
 
EXECUTIVE SUMMARY 
  MARKET SCENARIO
 
1 INTRODUCTION
  1.1 KEY TAKE-AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY
 
2 SUMMARY
 
3 MARKET OVERVIEW
  3.1 INTRODUCTION
  3.2 DEFINITION OF RESPIRATORY CARE MARKET
  3.3 EVOLUTION OF RESPIRATORY CARE MARKET
  3.4 DRIVERS
      3.4.1 HIGH PREVALENCE OF RESPIRATORY DISEASES
      3.4.2 CHANGING LIFESTYLE & INCREASING NUMBER OF SMOKERS
      3.4.3 GROWING NUMBER OF AGED PEOPLE
      3.4.4 TECHNOLOGICAL ADVANCEMENTS
  3.5 RESTRAINTS
      3.5.1 ECONOMIC SLOWDOWN
  3.6 KEY TRENDS
      3.6.1 EMERGING ECONOMIES DEMAND COST-EFFICIENT EQUIPMENT
      3.6.2 INCREASING FOCUS ON COMPACT DEVICES FOR DIAGNOSTICS
  3.7 PAP DEVICES DOMINATE THERAPEUTICS AREA
  3.8 CAPNOGRAPHY DEVICE AS POPULAR MONITORING EQUIPMENT
  3.9 SPIROMETERS CONTINUE TO LEAD RESPIRATORY DIAGNOSTIC DEVICES MARKET
  3.10 PATENT ANALYSIS
      3.10.1 RESMED FOCUSING ON THE THERAPEUTICS SEGMENT
      3.10.2 DEVICE MANUFACTURERS FOCUSING ON VENTILATORS & INHALERS SEGMENTS
 
4 RESPIRATORY CARE THERAPEUTICS DEVICES
  4.1 INTRODUCTION
  4.2 DRIVERS
      4.2.1 HOME HEALTHCARE GROWTH LEADING TO INCREASED DEMAND FOR THERAPEUTIC DEVICES
      4.2.2 USER-FRIENDLY SYSTEMS & TECHNOLOGY INCREASES ADOPTION OF DEVICES
  4.3 RESTRAINTS
      4.3.1 MARKET SATURATION
      4.3.2 HIGH COST OF OWNERSHIP RESTRICTS THE ADOPTION OF DEVICES
  4.4 OPPORTUNITIES
      4.4.1 USED IN DELIVERY OF VACCINES, SYSTEMIC THERAPY & GENE-REPLACEMENT THERAPY
  4.5 BURNING ISSUES
      4.5.1 BAN ON CHLOROFLUOROCARBON BASED PROPELLANTS
      4.5.2 REDUCTION IN THE REIMBURSEMENT AMOUNT FOR HOME OXYGEN
  4.6 WINNING IMPERATIVES
      4.6.1 LOWER OPERATING COSTS & PACKAGING GIVES LONG TERM ADVANTAGE
      4.6.2 PORTABILITY IS A KEY DISTINGUISHING FEATURE
  4.7 HUMIDIFIERS
      4.7.1 HEATED HUMIDIFIERS
      4.7.2 PASSOVER HUMIDIFIERS
  4.8 FURTHER CLASSIFICATION OF HEATED & PASSOVER HUMIDIFIERS
      4.8.1 INTEGRATED HUMIDIFIERS
      4.8.2 BUILT-IN HUMIDIFIERS
      4.8.3 STAND-ALONE HUMIDIFIERS
  4.9 NEBULIZERS
      4.9.1 COMPRESSOR-BASED NEBULIZERS
      4.9.2 PISTON BASED HAND-HELD NEBULIZERS
      4.9.3 ULTRASONIC NEBULIZERS
  4.10 OXYGEN CONCENTRATORS
      4.10.1 FIXED OXYGEN CONCENTRATORS
      4.10.2 PORTABLE OXYGEN CONCENTRATORS
  4.11 POSITIVE AIRWAY PRESSURE (PAP) DEVICES
      4.11.1 CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
      4.11.2 OTHER PAP DEVICES
             4.11.2.1 TBi-level PAP devices & automatic PAP devices
  4.12 REUSABLE RESUSCITATORS
  4.13 VENTILATORS
      4.13.1 ADULT VENTILATORS
      4.13.2 NEONATAL VENTILATORS
  4.14 RESPIRATORY INHALERS
      4.14.1 DRY POWDER INHALERS
      4.14.2 METERED DOSE INHALERS
 
5 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES
  5.1 INTRODUCTION
  5.2 DRIVERS & RESTRAINTS
      5.2.1 RISING FOCUS ON MONITORING RESPIRATORY DISEASES
      5.2.2 HIGH LEVEL OF SATURATION IN PULSE OXIMETERS 
  5.3 BURNING ISSUES
      5.3.1 WHO INITIATIIVE FOR DEVELOPING COST EFFECTIVE OXIMETERS
  5.4 WINNING IMPERATIVES
      5.4.1 FOCUS ON ADDITIONAL FEATURES TO GAIN COMPETITIVE EDGE
      5.4.2 USP IS COMPACTNESS OF DEVICES
  5.5 RESPIRATORY CARE MONITORING DEVICES
      5.5.1 PULSE OXIMETER
            5.5.1.1 Pulse oximeter equipment
                    5.5.1.1.1 Handheld pulse oximeters
                    5.5.1.1.2 Fingertip pulse oximeters
                    5.5.1.1.3 Tabletop pulse oximeters
                    5.5.1.1.4 Wrist worn pulse oximeters
            5.5.1.2 Pulse oximeter sensors
      5.5.2 CAPNOGRAPHS
      5.5.3 GAS ANALYZERS
  5.6 RESPIRATORY DISPOSABLES
      5.6.1 DISPOSABLE OXYGEN MASK
      5.6.2 DISPOSABLE RESUSCITATORS
      5.6.3 TRACHEOSTOMY TUBES
      5.6.4 OXYGEN CANNULAE
 
6 RESPIRATORY CARE DIAGNOSTIC DEVICES  (RESPIRATORY MEASUREMENT DEVICES) 
  6.1 INTRODUCTION
  6.2 DRIVERS & RESTRAINTS
      6.2.1 DEVELOPING ECONOMIES PROVIDE A GROWING DIAGNOSTICS MARKET
      6.2.2 COMPLICATED REIMBURSEMENT PROCESS IN DIAGNOSTICS SEGMENT
      6.2.3 HIGHLY COMPETITIVE
  6.3 OPPORTUNITIES
      6.3.1 POINT-OF-CARE DIAGNOSTICS AN UPCOMING OPPORTUNITY
  6.4 BURNING ISSUES & TRENDS
      6.4.1 SPIROMETRY IN TODDLERS/INFANTS  A CHALLENGE
      6.4.2 SPIROMETER ON IPHONE
  6.5 WINNING IMPERATIVES
      6.5.1 FOCUS ON ACCURATE &CLINICALLY IMPORTANT IMFORMATION
  6.6 SPIROMETER
      6.6.1 MECHANICAL VOLUME SPIROMETERS
      6.6.2 AUTOMATED FLOW SPIROMETERS
6.7 PEAK FLOW METERS
  6.8 RECORDERS/ POLYSOMNOGRAPHY DEVICES
  6.9 OTHER DIAGNOSTIC DEVICES
      6.9.1 EXERCISE TESTING EQUIPMENT
      6.9.2 PNEUMOTACHOMETERS
            6.9.2.1 Fleisch type pneumotachometers
            6.9.2.2 Lilly type pneumotachometers
      6.9.3 PLETHYSMOGRAPHS
 
7 PRETERM RESPIRATORY CARE DEVICES
  7.1 INTRODUCTION
  7.2 DRIVERS
      7.2.1 INCREASING INCIDENCE RATE OF PRETERM BIRTHS
      7.2.2 LARGE NUMBER OF INFANTS SUFFERING FROM RESPIRATORY DISTRESS SYNDROME
  7.3 RESTRAINTS
      7.3.1 HIGH ENTRY BARRIERS
      7.3.2 LOW COST VENTILATORS
  7.4 OPPORTUNITY
      7.4.1 MULTIFUNCTIONAL MEDICAL DEVICES
      7.4.2 SOFTWARE SOLUTIONS A HIGH GROWTH OPPORTUNITY
  7.5 BURNING ISSUES & TRENDS
      7.5.1 HARMFUL EFFECTS OF CERTAIN DEVICES
      7.5.2 INCREASING RESEARCH IN USE OF MICROPROCESSING TECHNOLOGY IN PRETERM DEVICES
  7.6 WINNING IMPERATIVES
      7.6.1 ROBUST DISTRIBUTION CHANNELS
      7.6.2 FOCUS ON SPECIFIC FEATURES BY THE MARKET PLAYERS
  7.7 INFANT VENTILATORS
  7.8 OXYGEN HOODS
  7.9 NASAL CPAPS
      7.10 ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)
      7.11 NITRIC OXIDE DELIVERY UNITS
  7.12 RESUSCITATORS
 
8 GEOGRAPHIC ANALYSIS
  8.1 INTRODUCTION
  8.2 U.S.
  8.3 EUROPE
  8.4 ASIA
  8.5 ROW
 
9 COMPETITIVE LANDSCAPE
  9.1 INTRODUCTION
  9.2 AGREEMENTS & PARTNERSHIPS/CONTRACTS/ALLIANCES
  9.3 MERGERS/ACQUISITIONS/COLLABORATIONS
  9.4 PRODUCT LAUNCH/PRODUCT INTEGRATION
  9.5 OTHERS
 
10 COMPANY PROFILES
  10.1 AIRSEP CORP
      10.1.1 OVERVIEW
      10.1.2 PRODUCTS & SERVICES
      10.1.3 STRATEGY
  10.2 ALLIED HEALTHCARE PRODUCTS
      10.2.1 OVERVIEW
      10.2.2 FINANCIALS
      10.2.3 PRODUCTS & SERVICES
      10.2.4 STRATEGY
      10.2.5 DEVELOPMENTS
  10.3 CAREFUSION CORP
      10.3.1 OVERVIEW
      10.3.2 FINANCIALS
      10.3.3 PRODUCTS & SERVICES
      10.3.4 STRATEGY
      10.3.5 DEVELOPMENTS
  10.4 COMPUMEDICS LTD
      10.4.1 OVERVIEW
      10.4.2 FINANCIALS
      10.4.3 PRODUCTS & SERVICES
      10.4.4 STRATEGY
      10.4.5 DEVELOPMENTS
  10.5 COVIDIEN, INC.
      10.5.1 OVERVIEW
      10.5.2 FINANCIALS
      10.5.3 PRODUCTS & SERVICES
      10.5.4 STRATEGY
      10.5.5 DEVELOPMENTS
  10.6 DEVILBISS HEALTHCARE
      10.6.1 OVERVIEW
      10.6.2 PRODUCTS & SERVICES
      10.6.3 STRATEGY
      10.6.4 DEVELOPMENTS
  10.7 DRAGER MEDICAL GMBH
      10.7.1 OVERVIEW
      10.7.2 PRODUCTS & SERVICES
      10.7.3 STRATEGY
  10.7.4 DEVELOPMENTS
      10.8 FISHER & PAYKEL
      10.8.1 OVERVIEW
      10.8.2 FINANCIALS
      10.8.3 PRODUCTS & SERVICES
      10.8.4 STRATEGY
      10.8.5 DEVELOPMENTS
  10.9 GE HEALTHCARE
      10.9.1 OVERVIEW
      10.9.2 PRODUCTS & SERVICES
      10.9.3 STRATEGY
      10.9.4 DEVELOPMENTS
  10.10 HAMILTON MEDICAL AG
      10.10.1 OVERVIEW
      10.10.2 PRODUCTS & SERVICES
      10.10.3 STRATEGY
      10.10.4 DEVELOPMENTS
  10.11 INVACARE CORP
      10.11.1 OVERVIEW
      10.11.2 FINANCIALS
      10.11.3 PRODUCTS & SERVICES
      10.11.4 STRATEGY
  10.12 MAQUET GMBH
      10.12.1 OVERVIEW
      10.12.2 PRODUCTS & SERVICES
      10.12.3 STRATEGY
      10.12.4 DEVELOPMENTS
  10.13 PHILIPS HEALTHCARE
      10.13.1 OVERVIEW
      10.13.2 PRODUCTS & SERVICES
      10.13.3 STRATEGY
      10.13.4 DEVELOPMENTS
  10.14 RESMED, INC.
      10.14.1 OVERVIEW
      10.14.2 FINANCIALS
      10.14.3 PRODUCTS & SERVICES
      10.14.4 STRATEGY
      10.14.5 DEVELOPMENTS

APPENDIX
  U.S. PATENTS
  EUROPE PATENTS
  JAPAN PATENTS 
  
LIST OF TABLES 

TABLE 1 GLOBAL RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION) 
TABLE 2 GLOBAL RESPIRATORY CARE THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION)
TABLE 3 GLOBAL RESPIRATORY CARE THERAPEUTIC DEVICES MARKET, BY PRODUCTS, 2008 2015 (UNIT SHIPMENTS IN THOUSANDS) 
TABLE 4 RESPIRATORY CARE THERAPEUTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 5 GLOBAL HUMIDIFIERS MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION)
TABLE 6 GLOBAL HUMIDIFIERS MARKET, BY PRODUCTS, 2008 2015 (UNIT SHIPMENTS IN THOUSANDS) 
TABLE 7 HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 8 HEATED HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 9 PASSOVER HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 10 NEBULIZERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 11 GLOBAL OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION)
TABLE 12 GLOBAL OXYGEN CONCENTRATORS MARKET, BY PRODUCTS, 2008 2015 (UNIT SHIPMENTS IN THOUSANDS) 
TABLE 13 OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 14 FIXED OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 15 PORTABLE OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 16 GLOBAL PAP DEVICES MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION)
TABLE 17 PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 18 CPAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 19 OTHER PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 20 REUSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 21 GLOBAL VENTILATORS MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION)
TABLE 22 GLOBAL VENTILATORS MARKET, BY PRODUCTS, 2008 2015  (UNIT SHIPMENTS IN THOUSANDS) 
TABLE 23 VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 24 ADULT VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 25 NEONATAL VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 26 GLOBAL RESPIRATORY INHALERS MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION)
TABLE 27 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCTS, 2008 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 28 RESPIRATORY INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 29 DRY POWDER INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 30 METERED DOSE INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 31 GLOBAL RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION)
TABLE 32 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 33 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION)
TABLE 34 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET, BY PRODUCTS, 2008 2015 (UNIT SHIPMENTS IN THOUSANDS) 
TABLE 35 RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 36 GLOBAL PULSE OXIMETRY MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION) 
TABLE 37 PULSE OXIMETRY MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 38 PULSE OXIMETERS EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 39 PULSE OXIMETER SENSORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 40 CAPNOGRAPHS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 41 GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 42 GLOBAL RESPIRATORY DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION) 
TABLE 43 GLOBAL RESPIRATORY DISPOSABLES MARKET, BY PRODUCTS, 2008 2015 (UNIT SHIPMENTS IN THOUSANDS) 
TABLE 44 RESPIRATORY DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 45 DISPOSABLES OXYGEN MASK MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 46 DISPOSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 47 TRACHEOSTOMY TUBES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 48 OXYGEN CANNULAE MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 49 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION)
TABLE 50 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET, BY PRODUCTS, 2008 2015 (UNIT SHIPMENTS IN THOUSANDS) 
TABLE 51 RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION) 
TABLE 52 SPIROMETERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 53 PEAK FLOW METERS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 54 POLYSOMNOGRAPHY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 55 OTHER DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 56 GLOBAL PRETERM RESPIRATORY CARE DEVICE MARKET REVENUE, BY PRODUCTS, 2008 2015 ($THOUSANDS) 
TABLE 57 PRETERM RESPIRATORY CARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($THOUSANDS) 
TABLE 58 INFANT VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($THOUSANDS)
TABLE 59 OXYGEN HOOD MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($THOUSANDS)
TABLE 60 NASAL CPAP MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($THOUSANDS)
TABLE 61 ECMO MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($THOUSANDS)
TABLE 62 NITRIC OXIDE DELIVERY UNIT MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($THOUSANDS)
TABLE 63 INFANT RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($THOUSANDS) 
TABLE 64 RESPIRATORY CARE MARKET REVENUE, BY GEOGRAPHY, 2008 2015 ($MILLION)
TABLE 65 U.S. RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION) 
TABLE 66 EUROPE RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION) 
TABLE 67 ASIA RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION) 
TABLE 68 ROW RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 2015 ($MILLION) 
TABLE 69 AGREEMENTS & PARTNERSHIPS, CONTRACTS, ALLIANCES (2008 2010) 
TABLE 70 MERGERS, ACQUISITIONS, COLLABORATIONS (2008 2011)
TABLE 71 NEW PRODUCTS, TECHNOLOGIES, SERVICES LAUNCHED (2009 2011) TABLE 72 OTHER DEVELOPMENTS IN THE RESPIRATORY CARE MARKET (2008 2011) 
TABLE 73 ALLIED HEALTHCARE PRODUCTS REVENUE & R&D EXPENSES ($MILLION)
TABLE 74 ALLIED HEALTHCARE PRODUCTS SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 75 ALLIED HEALTHCARE PRODUCTS SALES BY REGION ($MILLION)
TABLE 76 CAREFUSION CORPORATION REVENUE & R&D EXPENSES ($MILLION)
TABLE 77 CAREFUSION CORPORATION SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 78 CAREFUSION CORPORATION SALES BY REGION ($MILLION)
TABLE 79 COMPUMEDICS LIMITED SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 80 COMPUMEDICS LIMITED SALES BY REGION ($MILLION)
TABLE 81 COVIDIEN, INC. REVENUE AND R&D EXPENSES ($MILLION)
TABLE 82 COVIDIEN, INC. SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 83 COVIDIEN, INC. SALES BY REGION ($MILLION)
TABLE 84 FISHER & PAYKEL REVENUE AND R&D EXPENSES ($MILLION)
TABLE 85 FISHER & PAYKEL SALES BY REGION ($MILLION)
TABLE 86 INVACARE CORP REVENUE AND R&D EXPENSES ($MILLION)
TABLE 87 INVACARE CORP SALES BY REGION ($MILLION)
TABLE 88 RESMED, INC. REVENUE & R&D EXPENSES ($MILLION)
TABLE 89 RESMED, INC SALES BY REGION ($MILLION) 
  
LIST OF FIGURES  
 
FIGURE 1 SEGMENT WISE MARKET SHARE OF RESPIRATORY CARE DEVICES
FIGURE 2 GLOBAL RESPIRATORY CARE DEVICES MARKET BY SEGMENTS
FIGURE 3 RESPIRATORY CARE DEVICES MARKET SEGMENTATION
FIGURE 4 CHANGE IN TECHNOLOGY IN THERAPEUTICS, DIAGNOSTICS, & MONITORING DEVICES
FIGURE 5 SEGMENT ANALYSIS (RESPIRATORY THERAPEUTICS DEVICES)
FIGURE 6 SEGMENT ANALYSIS (RESPIRATORY MONITORING DEVICES)
FIGURE 7 SEGMENT ANALYSIS (RESPIRATORY DIAGNOSTIC DEVICES)
FIGURE 8 PATENTS BY MARKET PLAYERS (2005- MARCH 2011)
FIGURE 9 PATENTS BY SEGMENTS (2005- MARCH 2011)
FIGURE 10 MARKET SHARE FOR FIXED OXYGEN CONCENTRATORS
FIGURE 11 MARKET SHARE FOR PORTABLE OXYGEN CONCENTRATORS
FIGURE 12 MARKET SHARE FOR PULSE OXIMETER
FIGURE 13 MAJOR STRATEGIC FOCUS BY MARKET PLAYERS
FIGURE 14 MAJOR PLAYERS USING DIFFERENT STRATEGIES TO GROW

Global Respiratory Care Device Market (2010 - 2015)

The global respiratory care devices market has grown significantly over the past few years and is expected to grow at a steady pace in the coming five years. Rapidly aging population, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), technical advances in the respiratory care devices market, and tight budgets of healthcare institutions are the major factors influencing the market.

Positive airway pressure devices command the largest share in the respiratory care therapeutic devices segment. Technical advances such as portability, and increased battery life are primarily influencing the growth of this market.

The emergence of home healthcare has opened new avenues for the respiratory care devices market. Convenience and comfort in a home care environment coupled with cost advantages are the major factors driving the home healthcare market for respiratory care devices. The U.S. accounts for the largest share of the global respiratory care devices market. Demographic changes and rising incidence of COPD are among the major factors influencing the market. COPD is the fourth leading cause of death in the U.S.; about 12 million Americans suffer from COPD.

The global respiratory care market was expected to be worth $8.8 billion in 2010 and is estimated to reach $13.5 billion by 2015, growing at a CAGR of 8.8% from 2010-2015. The therapeutics devices market dominates the global respiratory care market, followed by monitoring devices and disposables. Within the therapeutics device market, positive airway pressure devices accounts for the largest share and is expected to be $5.2 billion by the year 2015. The pulse oximeters market dominates the respiratory monitoring devices segment and is expected to reach a market size of $1.7 billion by the year 2015. Within the respiratory diagnostic devices segment, spirometers dominate the market with an estimated share of $489 million by 2015.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports